Literature DB >> 20605247

Correlation between glucose fluctuations and carotid intima-media thickness in type 2 diabetes.

Xiao-min Chen1, Yan Zhang, Xing-ping Shen, Qun Huang, Hong Ma, Yang-Ling Huang, Wen-Qiang Zhang, Hao-Jie Wu.   

Abstract

AIMS: To evaluate the relationship between blood glucose fluctuations and carotid atherosclerosis (AS) in type 2 diabetic patients.
METHODS: A case-control study included 36 patients with type 2 diabetes and 10 controls. According to the levels of carotid intima-media thickness (CIMT), 36 diabetic patients were classified into two groups, the diabetes mellitus without atherosclerosis (DM-AS, n=20) and diabetes mellitus with atherosclerosis (DM+AS, n=16). The glucose excursions were assessed by the following parameters obtained from continuous glucose monitoring system for 72h: the mean blood glucose (MBG) and its standard deviation (SD), the area under the ROC curve when the blood glucose was higher than 7.8mmol/L (AUC7.8), the mean amplitude of glycemic excursion (MAGE), the mean of daily differences (MODD), and the largest amplitude of glycemic excursion (LAGE).
RESULTS: The levels of MBG, SD, MAGE, LAGE, and AUC7.8 were gradually increased with the progression of atherosclerosis (P<0.05). The Spearman's correlation analysis showed that the CIMT was correlated to the age (R=0.58, P<0.001), the duration (R=0.50, P<0.001), the MAGE (R=0.34, P=0.021), and the LAGE (R=0.31, P=0.035).
CONCLUSION: These results suggest that glucose fluctuations may accelerate atherogenesis in older type 2 diabetic patients who had a longer duration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20605247     DOI: 10.1016/j.diabres.2010.05.004

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  13 in total

Review 1.  Utility of different glycemic control metrics for optimizing management of diabetes.

Authors:  Klaus-Dieter Kohnert; Peter Heinke; Lutz Vogt; Eckhard Salzsieder
Journal:  World J Diabetes       Date:  2015-02-15

Review 2.  Cardiovascular disease and 1,5-anhydro-d-glucitol.

Authors:  Nobutaka Ikeda; Yukio Hiroi
Journal:  Glob Health Med       Date:  2019-12-31

3.  Updated Software for Automated Assessment of Glucose Variability and Quality of Glycemic Control in Diabetes.

Authors:  Vanessa Moscardó; Marga Giménez; Nick Oliver; Nathan R Hill
Journal:  Diabetes Technol Ther       Date:  2020-04-22       Impact factor: 6.118

4.  Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study.

Authors:  Annunziata Nusca; Angelo Lauria Pantano; Rosetta Melfi; Claudio Proscia; Ernesto Maddaloni; Rocco Contuzzi; Fabio Mangiacapra; Andrea Palermo; Silvia Manfrini; Paolo Pozzilli; Germano Di Sciascio
Journal:  J Diabetes Res       Date:  2015-07-26       Impact factor: 4.011

5.  Effect of repaglinide versus glimepiride on daily blood glucose variability and changes in blood inflammatory and oxidative stress markers.

Authors:  Masahiro Yamazaki; Goji Hasegawa; Saori Majima; Kazuteru Mitsuhashi; Takuya Fukuda; Hiroya Iwase; Mayuko Kadono; Mai Asano; Takafumi Senmaru; Muhei Tanaka; Michiaki Fukui; Naoto Nakamura
Journal:  Diabetol Metab Syndr       Date:  2014-05-05       Impact factor: 3.320

6.  Comparison of daily glucose excursion by continuous glucose monitoring between type 2 diabetic patients receiving biphasic insulin aspart 30 or biphasic human insulin 30.

Authors:  Akio Ohta; Tomoko Suwa; Yoshiyuki Sada; Hiroyuki Kato; Rieko Koganei; Shikou Asai; Takuyuki Katabami; Yasushi Tanaka
Journal:  J Diabetes Investig       Date:  2011-10-07       Impact factor: 4.232

Review 7.  Diabetes Mellitus, Arterial Wall, and Cardiovascular Risk Assessment.

Authors:  Michaela Kozakova; Carlo Palombo
Journal:  Int J Environ Res Public Health       Date:  2016-02-06       Impact factor: 3.390

8.  Glycemic variability is associated with subclinical atherosclerosis in Chinese type 2 diabetic patients.

Authors:  Yifei Mo; Jian Zhou; Mei Li; Yuwei Wang; Yuqian Bao; Xiaojing Ma; Ding Li; Wei Lu; Cheng Hu; Minghua Li; Weiping Jia
Journal:  Cardiovasc Diabetol       Date:  2013-01-15       Impact factor: 9.951

9.  Atherogenic subfractions of lipoproteins in the treatment of metabolic syndrome by physical activity and diet - the RESOLVE trial.

Authors:  Frédéric Dutheil; Guillaume Walther; Robert Chapier; George Mnatzaganian; Bruno Lesourd; Geraldine Naughton; Julien Verney; Anne Fogli; Vincent Sapin; Martine Duclos; Agnès Vinet; Philippe Obert; Daniel Courteix; Gérard Lac
Journal:  Lipids Health Dis       Date:  2014-07-11       Impact factor: 3.876

10.  Effects of daily glucose fluctuations on the healing response to everolimus-eluting stent implantation as assessed using continuous glucose monitoring and optical coherence tomography.

Authors:  Masaru Kuroda; Toshiro Shinke; Hiromasa Otake; Daisuke Sugiyama; Tomofumi Takaya; Hachidai Takahashi; Daisuke Terashita; Kenzo Uzu; Natsuko Tahara; Daiji Kashiwagi; Koji Kuroda; Yuto Shinkura; Yoshinori Nagasawa; Kazuhiko Sakaguchi; Yushi Hirota; Wataru Ogawa; Ken-Ichi Hirata
Journal:  Cardiovasc Diabetol       Date:  2016-05-21       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.